Doximity, Inc. (DOCS)

Market Cap	3.67B -67.9%
Revenue (ttm)	644.86M +13.1%
Net Income	196.05M -12.2%
EPS	0.98 -11.7%
Shares Out	179.75M
PE Ratio	20.84
Forward PE	14.25
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,181,148
Open	20.88
Previous Close	20.45
Day's Range	20.34 - 21.02
52-Week Range	17.15 - 76.51
Beta	1.29
Analysts	Buy
Price Target	24.61 (+20.52%)
Earnings Date	Aug 6, 2026

About DOCS

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools...

• Industry: Health Information Services
• Sector: Healthcare
• IPO Date: Jun 24, 2021
• Employees: 880
• Stock Exchange: NYSE
• Ticker Symbol: DOCS
• Website: https://www.doximity.com

Financial Performance

In fiscal year 2026, Doximity's revenue was $644.86 million, an increase of 13.05% compared to the previous year's $570.40 million. Earnings were $196.05 million, a decrease of -12.16%.

Analyst Summary

According to 21 analysts, the average rating for DOCS stock is "Buy." The 12-month stock price target is $24.61, which is an increase of 20.52% from the latest price.

Price Target

$24.61

(20.52% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Jul 25, 2026

Data Sources Report a data error